Data de publicação: 24/09/2021 - 10:24
As part of the preparations for the new Brazilian expedition to Antarctica, Fiocruz donated 3,000 rapid tests to detect Sars-Cov-2 antigens to the Navy. The kits, produced by the Institute of Technology in Immunobiologicals (Bio-Manguinhos/Fiocruz), will be used to test the entire crew on board, on the support flights, the team at the Comandante Ferraz Antarctic Station and the researchers who will be part of the new trip - including the...
Notícias
Data de publicação: 27/09/2021 - 18:04
Diseases that Brazilians are very familiar with, such as dengue fever, zika and chikungunya, are being directly affected by the pandemic, both with the transfer of human and material resources to the fight against COVID-19 and with possible undernotifications. But we can learn lessons from this experience, as shown by the 20th Advanced Seminaries on Global Health and Health Diplomacy of the Fiocruz Global Health Center (CRIS/Fiocruz), held last...
Notícias
Data de publicação: 02/09/2021 - 15:33
The Observatory of Climate and Health of the Institute of Scientific and Technological Communication and Information in Health (ICICT/Fiocruz), in a partnership with InfoAmazonia and the Federal University of Acre, invests in the project Engolindo Fumaça (Swallowing Smoke), a research on the impacts of the pollution resulting from wildfires in the Amazon during the COVID-19 pandemic. The forest fires and wildfires caused for...
Notícias
Data de publicação: 07/10/2021 - 17:11
A new study by Fiocruz on the effectiveness of vaccination in Brazil shows that the population has benefitted from the vaccination plan against the Sars-CoV-2 in the prevention of severe cases and deaths by Covid-19, although effectiveness varies between age groups. The analysis, which also included subjects vaccinated with the first dose of the Pfizer shot, was carried out between January 17 and July 19 this year, a total of six months, in...
Notícias
Data de publicação: 04/09/2021 - 12:50
The world is ageing, and it is not only in the wealthiest countries. In Brazil, this matter has an aggravating factor: while more developed nations become rich first and then age, Brazil is ageing in poverty, warns Alexandre Kalache. The president of the International Longevity Centre in Brazil, who is a doctor, was the mediator in the webinar Ageing, demographic changes and the pandemic, of the Fiocruz Global Health Center (CRIS/Fiocruz),...
Notícias
Data de publicação: 20/09/2021 - 18:30
Women are the majority in the healthcare workforce. Yet they are far from leadership positions, face unequal pay, and are often victims of bullying and sexual harassment. If the panorama described in the webinar Women in Global Health, promoted by the Fiocruz Global Health Center (Cris/Fiocruz) on the last 15th, seems bleak, it also brings foci of hope: at the same time that it exacerbated these inequalities, the COVID-19 pandemic shed light on...
Notícias
Data de publicação: 31/08/2021 - 13:20
An unprecedented survey by the Oswaldo Cruz Foundation (Fiocruz) shows that the number of COVID-19 deaths in Brazil in 2020 was 18.2% higher than recorded. The analysis indicated that there were 230,452 deaths from the disease last year, not 194,949. The results of the study, funded by the Fiocruz Program to Foster Innovation (Inova Fiocruz), will be published in the Fiocruz COVID-19 Monitoring panel.
Coordinator of the study, Cristiano...
Notícias
Data de publicação: 21/09/2021 - 15:48
A Swedish study with people infected by the Sars-CoV-2 and with subjects immunized with the Oxford/AstraZeneca (produced in Brazil by Fiocruz), Pfizer/BioNTech vaccines, and with people who were given one dose of each vaccine shows good protection 12 months after vaccination, against the so-called variants of concern. Submitted as preprint (without peer review), the research shows that two doses of the AstraZeneca vaccine result in the smallest...
Notícias
Data de publicação: 31/08/2021 - 10:26
The release of Aedes aegypti mosquitoes carrying Wolbachia in Niterói, in the state of Rio de Janeiro, which began as a pilot action in Jururuba, in 2015, and covered 75% of the city’s territory, has already yielded positive effects. Data released this Thursday (August 26th) by the Wolbachia Method, an initiative of the World Mosquito Program (WMP) led by Fiocruz in Brazil, indicate a reduction of about 70% of cases of dengue fever...
Notícias
Data de publicação: 13/10/2021 - 11:13
The ambassador of Botswana to Brazil, Tebogo Montshome, visited Fiocruz last Thursday (October 7th). She decided to get to know the Foundation while visiting Rio de Janeiro to identify areas of possible cooperation between her country and the institution. Greeted by the Vice-President of Production and Innovation in Health, Marco Krieger, Montshome was particularly interested in staff training, research and production of drugs and vaccines....
Notícias
Data de publicação: 03/11/2021 - 11:26
A new study published in Nature Communications last Thursday (28/11) shows that two doses of the AstraZeneca vaccine, produced in Brazil by Fiocruz, provide high protection against the Gamma variant in people above 60 years old. Based on São Paulo, the research shows that the second dose increases protection against death by about 30% when compared to the first dose, reaching an effectivity of 93.6%. Carried out by 20 researchers in...
Notícias
Data de publicação: 18/10/2021 - 12:05
A study led by the Center for the Integration of Data and Knowledge on Health (Cidacs/Fiocruz Bahia) suggests that C-sections may be associated with a higher risk of infant mortality, with the exception of cases in which a medical indication is clear on this procedure, which is popularly known as “cesarean” in Brazil.
Photo: Courtesy
Using data collected and provided by the Ministry of Health on more than 17 million...
Notícias
Data de publicação: 05/10/2021 - 17:22
Large-scale deforestation of the Amazon forest associated with climate change will increase the risk of exposure to extreme heat. Such levels of heat, which will be physiologically intolerable for the human body, will profoundly affect regions inhabited by highly vulnerable populations, according to a study published by researchers Beatriz Alves de Oliveira, of Fiocruz; Marcus Bottino and Paulo Nobre, both of the National Institute of Space...
Notícias
Data de publicação: 13/10/2021 - 15:53
Fiocruz will be part, starting next week, of a Phase 3 international multicenter study with the drug Molnupiravir, manufactured by the pharmaceutical company MSD. The goal is to verify its efficiency to prevent the COVID-19 spread and transmission among people exposed to the Sars-CoV-2 virus. The study will occur simultaneously in seven centers in Brazil, two of which are under the Fiocruz responsibility: Mato Grosso do Sul and Rio de Janeiro....
Notícias
Data de publicação: 03/08/2021 - 14:40
By means of the Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz), Fiocruz has reached 80.4 million doses of the COVID-19 vaccine made available to the National Immunization Program (PNI, in the Portuguese acronym), delivering approximately 2.2 million doses this Friday (July 30th). Of these, 76.4 million were processed at Fiocruz and 4 million were imported ready to use from the Serum Institute, in India. Another milestone of the...
Notícias
Data de publicação: 04/08/2021 - 17:11
An African word, Ubuntu, should guide the world leaders as a principle to tackle the COVID-19 pandemic. The statement is part of the commentary “COVID-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice”, published by The Lancet Regional Health – Americas in its first edition.
This Bantu language-derived African word reflects humanity and the interconnection amongst humans. As an example, the text...
Notícias
Data de publicação: 19/08/2021 - 11:59
On August 12th and 13th, the National University of Colombia (UNAL/Amazon Campus) hosted the 2nd Meeting of Health Researchers of the Triple Border (Brazil-Colombia-Peru). The meeting, organized by researchers of the Leônidas and Maria Deane Institute (ILMD/Fiocruz Amazônia), José Joaquín Carvajal Cortés and Adele Schwartz Benzaken, director of the Institution, aims at strengthening post-graduate programs through...
Notícias
Data de publicação: 16/08/2021 - 10:02
The long relationship between Fiocruz and the Special Program for Research and Training in Tropical Diseases of the World Health Organization (TDR/WHO) gained a more formal character with the signing of the memorandum of understanding (MoU) this past Wednesday (August 11th). The document, which establishes the technical cooperation terms for the confrontation of tropical and neglected diseases, was signed during a virtual meeting between...
Notícias
Data de publicação: 12/08/2021 - 11:20
Fiocruz, the State Government of Ceará and the State University of Ceará (UECE, acronym in Portuguese) sealed, this Thursday (8/5), a cooperation agreement for the development and production of the HH-120-Defenser vaccine against COVID-19, the elaboration of research projects and technological development. The agreement, signed by the Fiocruz president, Nísia Trindade Lima, and the Ceará governor, Camilo Santana...
Notícias
Data de publicação: 17/08/2021 - 16:53
Fiocruz will take on another challenge in the fight against COVID-19 with the production and supply of approximately 60 million antigen tests to the Ministry of Health (MS, the Portuguese acronym) by the end of 2021. Tests will be provided according to the demand of the ministry.
In addition to the production, Fiocruz will also be responsible for training the teams and providing technical and scientific assistance in the locations to be...
Notícias
Data de publicação: 17/08/2021 - 10:05
The British government wants to expand its scientific partnership with Fiocruz, especially in fields such as genomic sequencing, declared the minister counsellor of the British Embassy in Brazil, Melanie Hopkins, during a meeting with the president Nísia Trindade Lima, this Thursday (August, 12th). A month in office, the minister visited the Foundation accompanied by the consul general in Rio de Janeiro, Simon Wood.
British minister...
Notícias
Data de publicação: 09/08/2021 - 19:27
In the International Year of Health and Care Workers, this workforce is depleted. They have been the targets of applauses and assaults, seen old problems worsen, and become victims of the very COVID-19 they help fight. This panorama was outlined during the webinar Human Resources in Health in a Pandemic, promoted by the Fiocruz Global Health Center (CRIS/Fiocruz), on August 4th. With Francisco Eduardo Campos mediation, a public health and human...
Notícias
Data de publicação: 19/08/2021 - 10:10
In Manaus, the estimated population of pregnant women is 28.4 thousand, and of postpartum women, 4.7 thousand. According to data from the COVID-19 Manaus Vaccinometer, so far, only 6,606 pregnant women and 1,680 mothers have received the first dose of the vaccine. Coordinated by researchers from the Leônidas & Maria Deane Institute (Fiocruz Amazônia) and the Universidade Federal do Amazonas (UFAM), a study is investigating the...
Notícias
Data de publicação: 23/08/2021 - 10:04
The post-pandemic perspectives on Agenda 2030 in relation to issues such as health, human rights, and climate were addressed by the Advanced Seminars of the Fiocruz Global Health Center (CRIS/Fiocruz) this Wednesday (August, 18th). The event Agenda 2030: global stocktake and post-pandemic perspectives presented an updated assessment of the Sustainable Development Goals (SDGs) at global, regional and national levels, pointing out criticisms and...
Notícias
Data de publicação: 25/08/2021 - 12:33
Effectiveness studies of COVID-19 vaccines have demonstrated the immunization importance for protection against severe cases and hospitalization against the new variants. In June, data showed a 92% effectiveness of the AstraZeneca vaccine for hospitalizations against the Delta variant. Now, a new study coordinated by Oxford University in the United Kingdom points out that the Pfizer and AstraZeneca vaccines, this one produced in Brazil by...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
